Clinical trials of the vaccine from COVID-19 is scheduled to begin in the next two weeks. Volunteers for the tests already dialed. This was stated by the Minister of health, who took part in the opening of the infectious hospital in Ufa.
From the decision to delivery – 55 days. So much time was needed for the builders to clean the box under the Ufa appeared the hospital campus on 16 thousand square meters. Infectious hospital on 470 seats meets all the stringent requirements built not only fast, but also qualitatively. The staff is completed, it remains only to approve the schedule.
Each of the seven sections can work independently, self-filtration system waste water and air, which is especially important for hospital infectious profile. 100 chambers – insulated boxes with separate exits to the street. There is a separate electric line to connect the oxygen concentrator. Mobile devices are already purchased.
under normal conditions for the implementation of such a large project would be gone two years. But now this stock was not. Moreover, the building of the old infectious diseases hospital has long needed to be updated.
“This is an ordinary hospital, which will continue after this. The challenges we have ahead a lot, and infectious diseases has not been canceled,” — said the head of Bashkortostan radium Khabirov.
to Meet new challenges and adapt to new conditions the country’s health system learned in a very short time. The creation of vaccines against infectious diseases is a process that can take years. Russia reached the finish line just a couple of months, there are several promising developments. In two weeks to begin clinical trials.
“the Number of volunteers have been recruited, clinic trained. To complete the licensing of insurance procedures insurance. According to the results of the first clinical trials will start clinical use,” — said the Minister of health of the Russian Federation Mikhail Murashko.
And already tested samples of the vaccine against coronavirus may be ready by September. First and foremost, they will be available for medical professionals.
